In a recent example, the Dirks and Angers groups used genome-wide CRISPR screening and identified USP8 as one of the vulnerable genes from patient-derived glioblastoma stem cells and then validated USP8 to be an actionable therapeutic target using the lentiviral delivery of a UbV inhibitor [178]. Here, USP8 is linked to glioblastoma.